MacroGenics
MGNX
#8645
Rank
A$0.36 B
Marketcap
A$5.77
Share price
1.23%
Change (1 day)
113.14%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): A-$2.34

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$2.14. In 2025 the company made an earnings per share (EPS) of A-$1.65 a decrease over its 2024 EPS that were of A-$1.49.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$2.3441.89%
2025A-$1.6510.28%
2024A-$1.49613.33%
2023A-$0.21-92.31%
2022A-$2.72-42.14%
2021A-$4.7036.44%
2020A-$3.45-21.84%
2019A-$4.41-24.58%
2018A-$5.85675.93%
2017A-$0.75-68.05%
2016A-$2.36168.25%
2015A-$0.88-55%
2014A-$1.953400%
2013A-$0.05584-108.68%
2012A$0.6424.49%
2011A$0.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.83-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$39.41-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.22-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$10.36-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$4.99-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.97-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$3.20 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA